[Ed. Note: Dr. KSS writes for the Irregulars about medicine and biotech stocks. He has agreed to our trading restrictions, chooses his own topics, and his words and opinions are his own. Enjoy!] Readers not familiar with Stock Gumshoe usually arrive wondering if the salivation provoked by stock promotional writers for certain companies is justified. […]
560 Comments Read MoreBig Bucks from Big Prostates?
SDRL reaction Nov 26
2014’s Turkey of the Year
Benitec
Please forward my concern to Dr. KSS, I have been an irregular following his ideas from the beginning and occasionally participating. I do appreciate all the dedication that he puts in. I have had a sizable portion of my investment in Benitec and grew a bit worried just seeing a comment on twitter on an […]
7 Comments Read MoreWhat will be the effect of an OPEC Production cut?
Will OPEC cut enough to stop the slide in prices? Can shale producers survive below $75 bbl?
Leave a comment Read MoreVirginia Mines in Canada is merging with Orisko
Travis, Because I receive Adrian Day’s newsletter He made me aware of this opportunity to buy Virginia Mines on pink sheets, VGMNF. Virginia recently bought Altius which u own so you’re probably aware of this merger to create an intermediate royalty co. Do you think that Virginia Mines, VGMNF is a buy here at US […]
Leave a comment Read Moremoney map report Jim rickards
SFTBY
On March 19, 2014 Travis Johnson wrote an article about SFTBY as a way to get in on the BABA IPO. I would like his opinion as to why SFTBY, a 32% stakeholder in BABA has not moved up in view of the current BABA price of $110; A 70% increase since the IPO was […]
6 Comments Read MoreSandstorm Gold vers. Osisko Gold Royalities
Following the ”merger” of Virginia Mines and Osisko Gold Royalities the new company will be the fourth largest Royality company in the gold sector. The proposed dividend and share buyback programm next year will make the company more and more attractive. Nevertheless, the market capitalization of well over 1 billion seems very high to me! […]
Leave a comment Read MoreCracking The Code?
Any experience or knowledge of Chris Mayer and his ”Cracking the code with Wall Streets Secret Almanac”? I read his pitch and he’s asking a hefty chunk of change for the info.
Leave a comment Read MoreJingle Bells
As you will all know, Christmas is coming. I wondered if anyone had an idea what ’A Friend’ might want Santa to bring and whether youd like to contribute? Your call. BTW KSS, youre not allowed to read this thread.
102 Comments Read More“Bit stocks”
Porter Stansberry is pitching a new ”bit stock” portfolio that is beating the Dow by ”1000%” since October. Any clues as to what they are pushing now? I’ve gotten a half a dozen emails about this the last month.
Leave a comment Read MoreSkousen’s “The Best Company Money Can Buy Right Now”
Sniffing out some teaser picks from Forecasts and Strategies for the Friday File
2 Comments Read MoreCANF-Did IBuy a Turkey or a Golden Goose?
Down Fracking 10% from up 10% what does another < 1 % matter? Thus I bought 100 shares on basically no facts but a hell of a write up. I checked your site and found so many entries that I must conclude that this is the next 100 bagger or your data entry person/system got […]
Leave a comment Read MoreEnergy
After watching the Senate today on there 59- 41 wait till next years vote, I still think it will get more than it needs and would not doubt that they get the magic number so Obama’s veto can’t happen, but a lot can happen and they just gave the middle east more time on the […]
Leave a comment Read MoreSecond sight IPO
Hello, I was just wondering what opinions are out there on this upcoming IPO (EYES). It looks like they are going to price tomorrow.
Leave a comment Read MoreMoney Map Press $40k check
Uveitis Development orphan status
I just read (watched) a presentation from Mike Ward of Wall Street Insights & indictments for a biotech newsletter touting a $4 stock for a $28 million California company that has just received (or is about to) orphan status for a new Uveitis drug. ABBV has one listed, but is a $65 stock. Any one […]
20 Comments Read MoreUveitis Drug Bonanza?
With a sense of urgency I received this pitch (in a nutshell) Institutions and insiders – including the FDA’s former Chief Counsel – have snapped up 83% of available shares of the amazing company I’ve been telling you about. And for good reason. This tiny $4 company has developed a breakthrough drug to treat a […]
1 Comment Read MoreThe Oxford Bond Advantage
The picture’s name is Steve McDonald. Is this a new service or a re-run? It came from Bill Bonner, founder of Agora Inc. and a news letter called ”The Daily Grind” any knowledge, thoughts… Thanks
2 Comments Read More